The global Live Cell Encapsulation market size was estimated to be US$ 290 million in 2020 and is expected to reach US$ 430 million by 2031 at a CAGR of 3.7%.
Cell encapsulation presents a critical benefit contrasted with protein encapsulation, as cell encapsulation permits a supported and controlled delivery of required units at a consistent rate, accordingly, bringing about more significant physiological concentrates.
The encapsulation of cells, rather than helpful items, is utilized to permit the delivery of molecules required for a more extended time frame period as cells discharge these molecules of persistently. BioTime, Inc. (US) ruled the live cell encapsulation market during 2020. The organization has a solid geographic presence across the provinces like US, Australia, New Zealand, Israel, Canada, China, Japan, and Taiwan. BioTime, Inc. essentially is fixated around item commercialization to additionally reinforce its position in the live cell encapsulation market. Live Cell Encapsulation technology is encasing of live cells in defensive "capsules" measured of the top of a pin, intended to permit blood to enter and sustain the living cells inside them.
The capsules shield the live cells from obliteration by the safe arrangement of the body cells. The epitomized cells are delivered at a controlled rate inside the patient's body. Besides, such cells are utilized for directing in-vivo concentrates without influencing the host genome. For example, as per cancer research UK, there were around 14,957 instances of cases registered in 2019. Such high paces of cancerous growth are probably going to build demand for the utilization of new effective methods, for example, encapsulation just as an increase in the market demand for cellular research. North America is one of the significant incomes producing province in the live cell encapsulation market. The market in the Center East and Africa is probably going to represent the littlest portion of the worldwide live cell encapsulation market during 2022-2032.
Global Live Cell Encapsulation Market Value Share Analysis, by Geography (2021)
The report titled “Global Live Cell Encapsulation Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032”, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Live Cell Encapsulation Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Live Cell Encapsulation market is segmented based on Manufacturing Technique, Polymer type, Application and region. Based on Manufacturing Technique type, the Live Cell Encapsulation market is segmented into Simple Dripping, Electrostatic Dripping, Liquid Jet Break Up, Coaxial Airflow, Vibrating Jet, Jet Cutting, Rotating Disk Atomization, and others. Based on Polymer type, the Live Cell Encapsulation market is segmented into Alginate, HEMA-MMA, Chitosan, Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC, Other. Based on application type, the Live Cell Encapsulation market is segmented into Drug Delivery, Regenerative medicine, Cell Transplantation, Probiotics, Research, others.
Based on geography, the Global Live Cell Encapsulation Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Live Cell Encapsulation Market. Further, market share of prominent companies in the Global Live Cell Encapsulation Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Live Cell Encapsulation companies. The Global Live Cell Encapsulation Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Live Cell Encapsulation business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Live Cell Encapsulation Market.
The key players of the Global Live Cell Encapsulation Market are BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) Sigilon Therapeutics, Inc. (US), Evonik (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), and others.
Global Live Cell Encapsulation Market Key Segments:
By Manufacturing Technique type
By Polymer type
By Application type
By Region
The global Live Cell Encapsulation market was worth US$ 430 million in 2020.
The global Live Cell Encapsulation market is expected to register a CAGR of 3.7% between 2022 and 2032.
North America is the principal contributor to the global Live Cell Encapsulation market.
BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) Sigilon Therapeutics, Inc. (US), Evonik (Germany) are few prominent players active in the market.
The major applications of Live Cell Encapsulation include Drug Delivery, Regenerative medicine, Cell Transplantation, Probiotics and Research.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved